Search

everythinglearnresearchcommunity

for

Search:↓

Environmental pollutants can damage hair health and cause hair loss.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Thyroid problems can cause hair loss and change hair texture.

Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Certain hormone treatments can improve acne and related conditions in women.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

AGA more common in men, Koreans have lower rates and unique patterns.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Hair loss requires customized treatments based on its various causes and types.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Most acne patients were young males with face acne, with many experiencing worsening in summer and diet-related aggravation.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Immunizing goats against melatonin can temporarily change their cashmere growth cycles and increase fleece production.

Human skin can make serotonin and melatonin.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

Topical spironolactone effectively treats hair loss in women.

SLE and DM can coexist but are rare and need careful evaluation.

Vitamin A deficiency changes cattle hair structure, while pregnancy may improve it, suggesting hair can indicate cattle health.